Life sciences manufacturers are currently navigating a convergence of powerful market forces that are reshaping life sciences pricing strategy across Europe. The evolving regulatory landscape of the EU Health Technology Assessment (HTA) called the Joint Clinical Assessment (JCA), the rapid acceleration of digital procurement expectations, and growing Environmental, Social, and Governance (ESG) considerations are impacting the industry simultaneously.
Operating without a unified, structured operating model while responding to these forces introduces significant risk. Commercial and market access teams often experience slower operational cycles, excessive rework, and inconsistent pricing decisions across markets. To navigate this complexity successfully, organizations must move from reactive tactics to structured, scalable execution.
The most effective response requires coordinated adjustments to strategy, operations, and governance. For deeper examples and applied scenarios showing how leading organizations are futureproofing their operating models, watch the on-demand webinar Global Pricing and Tenders Trends: Navigating EU HTA/JCA, Digital Procurement and ESG, featuring Model N and Marbls, who pair pricing and tender strategy with hands-on execution experience.
How EU HTA/JCA Shifts the Planning Timeline
The introduction of EU HTA / JCA frameworks fundamentally alters traditional pricing and market access timelines. These frameworks introduce more stringent coordination requirements and demand a higher level of submission discipline from life sciences organizations.
Operationally, this regulatory shift forces commercial teams to adapt internal processes well before a product reaches the market. Pharmaceutical and medtech companies must establish earlier cross-functional alignment by bringing clinical, regulatory, market access, and pricing teams together during initial planning phases. Organizations also require stronger evidence readiness planning and more precise documentation to substantiate clinical and economic value propositions. Teams must anticipate national follow-through and carefully map how joint assessments will influence downstream pricing and reimbursement negotiations at the country level.
What to watch:
Timelines: Monitor accelerated deadlines for early joint scientific consultations.
Internal alignment: Ensure clinical and commercial teams share a unified data narrative.
Decision documentation: Maintain transparent records that support auditability across markets.
Digital Procurement Is Becoming the Default Tender Motion
Procurement authorities are actively modernizing purchasing processes. Digital procurement is transitioning from a specialized capability to a standard operational expectation.
In practice, digital procurement relies on electronic portals and highly standardized submission workflows. Procurement bodies increasingly demand structured tender responses and strict adherence to formatting and data requirements. As a result, commercial teams face faster submission cycles with minimal tolerance for manual processes or data inconsistencies.
For life sciences organizations, tender readiness must mature into a core operational capability. Effective global tender management depends on data readiness, rapid response speed, and repeatable execution across global, regional, and local levels.
Signal list for digital procurement trends:
- More standardized documentation requirements mandated by procurement portals.
- More frequent clarifications and structured, time-sensitive Q&A windows.
- Greater visibility and auditability expectations from contracting authorities.
ESG Is Moving Closer to Award Decisions
Sustainability and ethical business practices are no longer peripheral considerations. ESG factors are increasingly integrated into procurement conversations and are gaining influence within tender evaluation criteria.
Although adoption varies by region, the direction is consistent. Procurement authorities are starting to assign explicit weight to sustainability initiatives during award decisions. Meeting these requirements demands coordinated input from sustainability, compliance, supply chain, quality, and legal teams.
Organizations must ensure ESG messaging remains consistent across markets and individual tenders. Commercial teams must balance these qualitative requirements alongside established pricing, evidence, and value narratives.
The Response Is Operational, Not Just Strategic
Adapting to these converging forces requires more than high-level strategic alignment. Organizations must build a commercialization platform that translates strategy into precise and repeatable execution. The following three-pillar framework, shaped by Model N’s pricing and tender platform experience and Marbls’ operational advisory work, draws on practical guidance for strengthening pricing and tender operations.
Pillar A: Governance Clarity
A resilient operating model begins with clearly defined governance structures.
WHAT: Define which elements are governed, including approved price corridors, tender strategy guardrails, required approvals, and documented exceptions.
WHO: Establish decision rights across global, regional, and country levels, clarifying committee responsibilities and individual roles.
HOW: Map decision flows throughout the organization using standardized templates, defined timelines, structured approvals, and clear escalation paths.
Pillar B: Operational Change Control and Visibility
Organizations must eliminate reliance on siloed systems and manual spreadsheets. Commercial teams should standardize how price and tender changes are requested, reviewed, and approved.
Improved cross-market visibility reduces conflicting pricing actions and minimizes revenue leakage. Treating pricing and tender data as a core enterprise asset ensures compliance and accelerates accurate decision-making.
Pillar C: Scenario Planning Connected to Execution
Market access teams must assess financial risk before finalizing bids. Advanced scenario planning helps pressure-test pricing thresholds, tender conditions, and potential outcomes. Once strategies are approved, organizations must ensure clean translation into controlled execution and accurate tender submissions.
If a tender introduces new qualitative requirements, governance defines decision rights, operations deliver repeatable content and data, and scenario planning validates risk before submission.
Pricing and Tender Readiness Checklist
Assessing operational maturity is a critical step toward resilience. Consider the following questions:
- Do we have clear pricing and tender decision rights between global and local teams?
- Can we execute tenders through repeatable digital workflows with minimal manual effort?
- Are evidence, pricing, and market access teams aligned early in the product lifecycle?
- Do we maintain visibility into cross-market impacts of local pricing decisions?
- Can we address ESG and other qualitative requirements consistently and credibly?
- Do strategy decisions translate into controlled, compliant execution?
Futureproofing Your Operating Model
EU HTA/JCA regulations, digital procurement mandates, and rising ESG expectations are reshaping EU market access and pricing. While organizations cannot anticipate every regulatory change, they can build operating models that connect governance, accurate data, and agile execution. By unifying pricing, tender, and compliance processes on a single source of truth, life sciences manufacturers can adapt confidently to evolving market demands.
As regulatory and procurement pressures converge, pricing and tender excellence has become an execution challenge, not just a strategic one. Model N enables life sciences teams to operationalize pricing, tenders, and compliance with confidence. Contact us to learn how to build a resilient, future-ready operating model.
About Marbls
Marbls partners with pharmaceutical and medical device and diagnostic manufacturers to provide practical, innovative services that address complex pricing, contracting and commercial excellence needs — driving the path of critical drugs, devices, and diagnostics to market. Learn more at marblsgroup.com or reach out to themarblsteam@marblsgroup.com.
